← Back to Search

Dermal Filler

QM1114-DP for Frown Lines

Phase 3
Waitlist Available
Research Sponsored by Q-Med AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial looked at how well QM1114-DP works to improve the look of skin.

Eligible Conditions
  • Crow's Feet
  • Frown Lines

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Responders in QM1114-DP versus Placebo using the Global Aesthetic Improvement Scale (GAIS) at maximum frown at Month 1
Responders in QM1114-DP versus Placebo using the Global Aesthetic Improvement Scale (GAIS) at maximum smile at Month 1

Trial Design

1Treatment groups
Experimental Treatment
Group I: QM1114-DPExperimental Treatment1 Intervention
QM1114-DP
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
QM1114-DP
2022
Completed Phase 3
~630

Find a Location

Who is running the clinical trial?

Q-Med ABLead Sponsor
80 Previous Clinical Trials
12,640 Total Patients Enrolled
Galderma R&DLead Sponsor
298 Previous Clinical Trials
60,305 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for volunteers in this clinical trial?

"This research is no longer enrolling new patients. The listing for this project was first posted on 01/01/2023 and the most recent update occurred on 09/23/2022. If you are seeking other opportunities, please note that there are 8 clinical trials involving arterial lines and 68 studies related to QM1114-DP currently admitting participants."

Answered by AI

What are the primary benefits of taking QM1114-DP?

"QM1114-DP can ameliorate the symptoms of urinary incontinence, spinal cord damage, and botox side effects."

Answered by AI

What does the current research landscape look like for QM1114-DP?

"QM1114-DP is being researched in 68 different active studies, 22 of which are in Phase 3. Although the majority of these trials take place in Farmington Hills, Michigan, there are a total of 761 locations running studies for QM1114-DP."

Answered by AI

How many people have been selected to participate in this clinical trial?

"This study is not presently looking for participants at this time. The trial was originally posted on 1/1/2023 and was most recently updated on 9/23/2022. If you are seeking other studies, there are currently 8 studies actively looking for participants with arterial lines and 68 trials for QM1114-DP admitting patients."

Answered by AI

What are the possible risks associated with taking QM1114-DP?

"QM1114-DP's safety is reflected by its Phase 3 status. This means that not only is there some evidence of efficacy, but also that multiple rounds of testing have yielded positive results in terms of safety."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I have frown lines and crows feet.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
2023. "Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05148000.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top